Media headlines about Envision Healthcare (NYSE:EVHC) have trended somewhat positive this week, Accern Sentiment Analysis reports. The research firm scores the sentiment of press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Envision Healthcare earned a media sentiment score of 0.06 on Accern’s scale. Accern also assigned media coverage about the company an impact score of 45.7088934608626 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

These are some of the news headlines that may have impacted Accern Sentiment Analysis’s scoring:

EVHC has been the subject of several analyst reports. Canaccord Genuity restated a “buy” rating and issued a $86.00 price objective on shares of Envision Healthcare in a research note on Tuesday, April 18th. BidaskClub upgraded Envision Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, June 17th. Zacks Investment Research upgraded Envision Healthcare from a “strong sell” rating to a “buy” rating and set a $70.00 price objective for the company in a research note on Tuesday, July 4th. Cantor Fitzgerald restated a “buy” rating on shares of Envision Healthcare in a research note on Monday, July 24th. Finally, Royal Bank Of Canada upped their price objective on Envision Healthcare from $72.00 to $77.00 and gave the stock an “outperform” rating in a research note on Tuesday, June 27th. One investment analyst has rated the stock with a sell rating, two have issued a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. Envision Healthcare currently has an average rating of “Buy” and a consensus target price of $71.56.

Shares of Envision Healthcare (NYSE EVHC) opened at 52.89 on Friday. Envision Healthcare has a 52 week low of $51.44 and a 52 week high of $74.75. The firm has a 50-day moving average price of $59.31 and a 200-day moving average price of $61.09. The stock’s market cap is $6.19 billion.

Envision Healthcare (NYSE:EVHC) last released its earnings results on Monday, August 7th. The company reported $0.79 EPS for the quarter, topping analysts’ consensus estimates of $0.75 by $0.04. The business had revenue of $1.95 billion during the quarter, compared to analysts’ expectations of $1.96 billion. Envision Healthcare had a negative net margin of 7.35% and a positive return on equity of 5.35%. The company’s quarterly revenue was up 156.7% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.34 earnings per share. On average, equities analysts anticipate that Envision Healthcare will post $1.40 earnings per share for the current year.

In other news, insider Robert Jon Coward sold 1,500 shares of the business’s stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $62.69, for a total transaction of $94,035.00. Following the completion of the sale, the insider now owns 97,863 shares of the company’s stock, valued at $6,135,031.47. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 3.10% of the stock is owned by insiders.

COPYRIGHT VIOLATION NOTICE: “Envision Healthcare (EVHC) Earns Media Impact Rating of 0.06” was first reported by Daily Political and is the sole property of of Daily Political. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this report can be read at

About Envision Healthcare

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Insider Buying and Selling by Quarter for Envision Healthcare (NYSE:EVHC)

Receive News & Ratings for Envision Healthcare Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare Co. and related companies with's FREE daily email newsletter.